WhichRecall
Class IIReported 2026-03-18

Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7

Recalled by Zydus Pharmaceuticals (USA) Inc

Reason for Recall

Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Advertisement
Recall Number
D-0400-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2026-03-09
Reported
2026-03-18
Distribution
Nationwide in the USA
Code Info
Lot #: S2520249, S2520250, S2520267, Exp. Date 2027/Jan; S2520303, S2520305, S2520332, Exp. Date 2027/Feb; S2540208, S2540209, Exp. Date 2027/Apr
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement